Perfromance Wealth Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,000
| Closed | -$238K | – | 201 |
|
|
2024
Q2 | $238K | Buy |
+2,000
| New | +$238K | 0.01% | 139 |
|
|
2023
Q2 | – | Sell |
-1,509
| Closed | -$232K | – | 189 |
|
|
2023
Q1 | $232K | Sell |
1,509
-1,101
| -42% | -$169K | 0.01% | 161 |
|
|
2022
Q4 | $469K | Buy |
2,610
+400
| +18% | +$71.8K | 0.03% | 106 |
|
|
2022
Q3 | $261K | Sell |
2,210
-700
| -24% | -$82.7K | 0.02% | 131 |
|
|
2022
Q2 | $416K | Hold |
2,910
| – | – | 0.02% | 107 |
|
|
2022
Q1 | $501K | Buy |
2,910
+1,200
| +70% | +$207K | 0.02% | 108 |
|
|
2021
Q4 | $434K | Buy |
+1,710
| New | +$434K | 0.02% | 123 |
|